Found 17 results
Filters: Author is Amor-Coarasa, Alejandro  [Clear All Filters]
2022
Kelly JM, Jeitner TM, Waterhouse NN, Qu W, Linstad EJ, Samani B, Williams C, Nikolopoulou A, Amor-Coarasa A, DiMagno SG et al..  2022.  Synthesis and Evaluation of C-Labeled Triazolones as Probes for Imaging Fatty Acid Synthase Expression by Positron Emission Tomography.. Molecules. 27(5)
2021
Kelly JM, Amor-Coarasa A, Sweeney E, Wilson JJ, Causey PW, Babich JW.  2021.  A suitable time point for quantifying the radiochemical purity of Ac-labeled radiopharmaceuticals.. EJNMMI Radiopharm Chem. 6(1):38.
2020
Kelly JM, Ponnala S, Amor-Coarasa A, Zia NA, Nikolopoulou A, Williams C, Schlyer DJ, DiMagno SG, Donnelly PS, Babich JW.  2020.  Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for Cu/Cu-Based Theranostics in Prostate Cancer.. Mol Pharm. 17(6):1954-1962.
2019
Amor-Coarasa A, Kelly JM, Babich JW.  2019.  3D-printed automation for optimized PET radiochemistry.. Sci Adv. 5(9):eaax4762.
Kelly JM, Amor-Coarasa A, Ponnala S, Nikolopoulou A, Williams C, DiMagno SG, Babich JW.  2019.  Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window.. J Nucl Med. 60(5):656-663.
Amor-Coarasa A, Kelly JM, Singh PK, Ponnala S, Nikolopoulou A, Williams C, Vedvyas Y, Jin MM, J Warren D, Babich JW.  2019.  [F]Fluoroethyltriazolyl Monocyclam Derivatives as Imaging Probes for the Chemokine Receptor CXCR4.. Molecules. 24(8)
Kelly JM, Amor-Coarasa A, Ponnala S, Nikolopoulou A, Williams C, Thiele NA, Schlyer D, Wilson JJ, DiMagno SG, Babich JW.  2019.  A Single Dose of Ac-RPS-074 Induces a Complete Tumor Response in an LNCaP Xenograft Model.. J Nucl Med. 60(5):649-655.
2018
Amor-Coarasa A, Kelly J, Ponnala S, Vedvyas Y, Nikolopoulou A, Williams C, Jin MM, J Warren D, Babich JW.  2018.  [F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4.. Nucl Med Biol. 60:37-44.
Amor-Coarasa A, Kelly JM, Ponnala S, Nikolopoulou A, Williams C, Babich JW.  2018.  Ga: A Novelty or a Valuable Preclinical Screening Tool for the Design of Targeted Radiopharmaceuticals? Molecules. 23(10)
Kelly J, Amor-Coarasa A, Ponnala S, Nikolopoulou A, Williams C, Schlyer D, Zhao Y, Kim D, Babich JW.  2018.  Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors.. Eur J Nucl Med Mol Imaging. 45(11):1841-1851.
2017
Kelly JM, Amor-Coarasa A, Nikolopoulou A, Kim D, Williams C, Vallabhajosula S, Babich JW.  2017.  Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of Ga, In, Lu and Ac.. Nucl Med Biol. 55:38-46.
Amor-Coarasa A, Kelly JM, Gruca M, Nikolopoulou A, Vallabhajosula S, Babich JW.  2017.  Continuation of comprehensive quality control of the itG Ge/Ga generator and production of Ga-DOTATOC and Ga-PSMA-HBED-CC for clinical research studies.. Nucl Med Biol. 53:37-39.
Kelly JM, Amor-Coarasa A, Nikolopoulou A, Wüstemann T, Barelli P, Kim D, Williams C, Zheng X, Bi C, Hu B et al..  2017.  Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer.. J Nucl Med. 58(9):1442-1449.
Thiele NA, Brown V, Kelly JM, Amor-Coarasa A, Jermilova U, MacMillan SN, Nikolopoulou A, Ponnala S, Ramogida CF, Robertson AKH et al..  2017.  An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy.. Angew Chem Int Ed Engl. 56(46):14712-14717.
Kelly J, Amor-Coarasa A, Nikolopoulou A, Kim D, Williams C, Ponnala S, Babich JW.  2017.  Synthesis and pre-clinical evaluation of a new class of high-affinity F-labeled PSMA ligands for detection of prostate cancer by PET imaging.. Eur J Nucl Med Mol Imaging. 44(4):647-661.
2016
Vedvyas Y, Shevlin E, Zaman M, Min IM, Amor-Coarasa A, Park S, Park S, Kwon K-W, Smith T, Luo Y et al..  2016.  Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors.. JCI Insight. 1(19):e90064.